• Aerospace
  • Agriculture
  • Consumer Services
  • Healthcare
  • Energy And Resources
  • Food & Beverages
  • Electric Equipments
  • Materials And Chemicals
  • Semiconductor
  • Technology And Media
  • Transportation And Shipping
  • Automobile & Transportation
  • Chemical & Material
  • Medical Devices
  • Banking
  • Drugs By Therapeutics Area
  • Oncology Drugs
  • Therapeutics Area
  • Healthcare services
  • Diagnostics
  • Laboratory Equipment
  • Metals And Minerals
  • Rubber
  • Consumer Electronics
  • Personal care products
  • Travel And Tourism
  • Energy & Power
  • Computing And Technology
  • Electronics
  • Food Ingredients
  • Military
  • Defense
  • Machinery & Equipment
  • Heavy Industries
  • Industrial Automation
  • Asia Pacific
  • Pharmaceutical
  • NanoTechnology
  • Vaccines
  • Consumer Goods
  • Others
  • Service & Software
CD 40 Inhibitor

CD 40 Inhibitor

Date: Jan-2019 | Id: MACRC-0901 | Geographical Scope: Global

This report can be delivered to the clients within 1-2 Business Days. CmaxInsight’s, “CD 40 Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MoA). A key objecti...

CCR4 Inhibitor

CCR4 Inhibitor

Date: Jan-2019 | Id: MACRC-0895 | Geographical Scope: Global

This report can be delivered to the clients within 1-2 Business Days. CmaxInsight’s, “CCR4 Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MoA). A key objectiv...

Anti-CD40 Antibody

Anti-CD40 Antibody

Date: Jan-2019 | Id: MACRC-0841 | Geographical Scope: Global

This report can be delivered to the clients within 1-2 Business Days. CmaxInsight’s, “Anti-CD40 Antibody-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MoA). A key obje...

Anti-CD274 (PD-L1) Antibody

Anti-CD274 (PD-L1) Antibody

Date: Jan-2019 | Id: MACRC-0834 | Geographical Scope: Global

This report can be delivered to the clients within 1-2 Business Days. CmaxInsight’s, “Anti-CD274 (PD-L1) Antibody-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MoA). A...

Alpha 4 Beta 7 (A4b7) Integrin Inhibitor

Alpha 4 Beta 7 (A4b7) Integrin Inhibitor

Date: Jan-2019 | Id: MACRC-0805 | Geographical Scope: Global

This report can be delivered to the clients within 1-2 Business Days. CmaxInsight’s, “Alpha 4 Beta 7 (A4b7) Integrin Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of ac...

Alpha 4 Beta 2 Neuronal Nicotinic Receptor (NNR) Agonist

Alpha 4 Beta 2 Neuronal Nicotinic Receptor (NNR) Agonist

Date: Jan-2019 | Id: MACRC-0804 | Geographical Scope: Global

This report can be delivered to the clients within 1-2 Business Days. CmaxInsight’s, “Alpha 4 Beta 2 Neuronal Nicotinic Receptor (NNR) Agonist-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this...

5-HT4 Partial Agonist

5-HT4 Partial Agonist

Date: Jan-2019 | Id: MACRC-0785 | Geographical Scope: Global

This report can be delivered to the clients within 1-2 Business Days. CmaxInsight’s, “5-HT4 Partial Agonist-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MoA). A key o...

5-HT4 Antagonist

5-HT4 Antagonist

Date: Jan-2019 | Id: MACRC-0784 | Geographical Scope: Global

This report can be delivered to the clients within 1-2 Business Days. CmaxInsight’s, “5-HT4 Antagonist-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MoA). A key object...

5-HT4 Agonist

5-HT4 Agonist

Date: Jan-2019 | Id: MACRC-0783 | Geographical Scope: Global

This report can be delivered to the clients within 1-2 Business Days. CmaxInsight’s, “5-HT4 Agonist-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MoA). A key objective...

4-1BB receptor Agonist

4-1BB receptor Agonist

Date: Jan-2019 | Id: MACRC-0768 | Geographical Scope: Global

This report can be delivered to the clients within 1-2 Business Days. CmaxInsight’s, “4-1BB receptor Agonist-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MoA). A key ...